Blood eosinophil-guided asthma care in primary care
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests whether using a blood test (eosinophil count) to guide asthma treatment works better than usual care for people with mild to moderate asthma. If you have asthma and are on step 1-3 treatment, this study could help improve your symptom control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Singapore citizen or permanent resident.
- You are between 21 and 65 years old.
- You have been diagnosed with asthma by a doctor for at least 4 weeks.
- You are currently on or about to start step 1-3 asthma treatment (like low-dose inhalers).
- You have not had an asthma flare-up needing steroids or a hospital visit in the last 4 weeks.
- You can attend study visits about every 4 months for 1 year.
- You have stable heart health (e.g., controlled blood pressure, no active heart symptoms).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how eosinophils (a type of white blood cell) work in asthma, including in people who have not responded to certain biologic treatments. By joining, you may help researchers understand asthma better and potentially improve future treatments.
This study looks at how to improve care for people with eosinophilic esophagitis (EoE), a condition that causes inflammation in the esophagus. It may help you if you have or are being checked for EoE.
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
This study tests if adding a new injectable medicine (benralizumab) to your current medium-dose inhaler works better than simply increasing your inhaler dose to control hard-to-treat asthma. It may help people with a specific type of asthma linked to high eosinophil levels.
This study looks at different types of eosinophils (a type of white blood cell) in people with asthma, EGPA, or HES. It aims to help doctors better understand these conditions and could guide future treatments.
This trial tests a new nasal spray (AD17002) for people with moderate to severe eosinophilic asthma, a type of asthma with high eosinophil blood cells. The spray is self-administered at home, and the study aims to see if it is safe and helps control asthma.
Hear when a new Asthma Exacerbations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.